VOLPATO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 940
EU - Europa 820
AS - Asia 334
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 2.169
Nazione #
US - Stati Uniti d'America 940
GB - Regno Unito 232
VN - Vietnam 175
SE - Svezia 172
IT - Italia 119
DE - Germania 113
CN - Cina 86
IN - India 52
IE - Irlanda 37
FR - Francia 28
RU - Federazione Russa 25
NG - Nigeria 22
BG - Bulgaria 20
TG - Togo 20
EE - Estonia 17
ZA - Sudafrica 17
UA - Ucraina 14
CH - Svizzera 12
CI - Costa d'Avorio 11
BE - Belgio 10
FI - Finlandia 9
JO - Giordania 8
IR - Iran 6
EU - Europa 4
ES - Italia 3
GR - Grecia 3
UZ - Uzbekistan 3
HR - Croazia 2
MK - Macedonia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
LB - Libano 1
NL - Olanda 1
SG - Singapore 1
TR - Turchia 1
Totale 2.169
Città #
Southend 219
Dong Ket 156
Chandler 138
Fairfield 115
Ashburn 68
Ann Arbor 56
Houston 53
Wilmington 53
Woodbridge 48
Princeton 44
Seattle 40
Dublin 37
Bologna 35
Cambridge 32
Beijing 23
Abeokuta 22
Lomé 20
Sofia 20
New York 18
Padova 18
Westminster 18
Medford 15
Nanjing 15
Berlin 14
Mountain View 13
Abidjan 11
Bern 11
Brussels 10
Saint Petersburg 10
Shenyang 10
Bremen 9
Florence 9
Helsinki 9
Amman 8
Boardman 8
Norwalk 6
Redwood City 6
Turin 6
Changsha 5
Hebei 5
Jinan 5
Nanchang 5
San Diego 5
Des Moines 4
Haikou 4
Monmouth Junction 4
Napoli 4
Paris 4
Bühl 3
Falls Church 3
Pianoro 3
Redmond 3
Taizhou 3
Andover 2
Bitola 2
Jiaxing 2
Leawood 2
London 2
Milan 2
Montegaldella 2
Portland 2
Rome 2
Vijayawada 2
Washington 2
Zhengzhou 2
Aarau 1
Albacete 1
Barcelona 1
Brisbane 1
Büdelsdorf 1
Castel Maggiore 1
Cedar Knolls 1
Cesenatico 1
Den Haag 1
Dhaka 1
Duncan 1
Falkenstein 1
Ferrara 1
Forlì 1
Frankfurt Am Main 1
Fremont 1
Hangzhou 1
Hyderabad 1
Kashan 1
Kilburn 1
Kish 1
Kyiv 1
Los Angeles 1
New Delhi 1
Ningbo 1
Olalla 1
Portici 1
Porto Sant'elpidio 1
Pune 1
San Francisco 1
San Giorgio 1
Sassari 1
Singapore 1
Somerton 1
Tianjin 1
Totale 1.522
Nome #
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 180
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 177
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 173
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 117
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 113
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 111
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 108
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up 106
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 105
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 104
SNP array reveals a new deletion of JAK2 in AML patients 103
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 84
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 83
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 82
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 79
null 78
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 77
Gene expression signature of aneuploidy in acute myeloid leukemia 76
Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia 73
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir 54
null 52
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study 44
Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature 33
Posterior reversible encephalopathy syndrome in a B-cell acute lymphoblastic leukemia young adult patient treated with a pediatric-like chemotherapeutic schedule 26
Totale 2.238
Categoria #
all - tutte 5.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 0 4 29
2019/2020429 66 19 2 23 39 34 53 54 57 36 29 17
2020/2021427 44 14 6 3 9 17 8 25 39 23 34 205
2021/2022471 22 17 22 50 49 21 14 28 24 51 92 81
2022/2023552 49 77 20 89 53 46 14 34 100 7 37 26
2023/2024156 10 26 7 15 15 51 9 7 7 7 2 0
Totale 2.238